CLOs on the Move

Polychromix

www.polychromix.com

 
Polychromix is a Wilmington, MA-based company in the Business Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Focused Quality Solutions

Focused Quality Solutions is a Milford, OH-based company in the Business Services sector.

Hauge Associates Inc

Hauge Associates Inc is a Sioux Falls, SD-based company in the Business Services sector.

Hjm Precision Inc

Hjm Precision Inc is a Troy, NY-based company in the Business Services sector.

Meta Aerospace

Meta provides solutions to national security problems, leveraging commercial business models to unleash innovation cycles that anticipate emerging threats.

Mural Oncology

We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)